Extraction and Simultaneous Quantification of Endocannabinoids and Endocannabinoid-Like Lipids in Biological Tissues

  • Laura Bindila
  • Beat LutzEmail author
Part of the Methods in Molecular Biology book series (MIMB, volume 1412)


Extraction and quantification of endocannabinoids (eCBs) from biological tissues are essential to unravel their changes in physiological and pathophysiological conditions. We describe here an analytical protocol for extraction of endocannabinoids, anandamide (AEA) and 2-arachidonoyl glycerol (2-AG), endocannabinoid-like lipids such as palmitoyl ethanolamide (PEA) and oleoyl ethanolamide (OEA), as well as arachidonic acid (AA) from biological tissues using liquid-liquid extraction method and simultaneous quantification by liquid chromatography multiple reaction monitoring (LC/MRM).

Key words

Endocannabinoids Endocannabinoid-like lipids Liquid-chromatography Multiple reaction monitoring Lipid extraction 



This work has been financially supported by Collaborative Research Unit of the German Research Council FOR926 (central project CP1) and BMBF collaborative project LOGIN. We thank Claudia Schwitter, Raissa Lerner, and Julia Post for technical support in establishing the protocols.


  1. 1.
    Zoerner AA, Gutzki FM, Batkai S et al (2011) Quantification of endocannabinoids in biological systems by chromatography and mass spectrometry: a comprehensive review from an analytical and biological perspective. Biochim Biophys Acta 1811:706–723CrossRefPubMedGoogle Scholar
  2. 2.
    Buczynski MW, Parsons LH (2010) Quantification of brain endocannabinoid levels: methods, interpretations and pitfalls. Br J Pharmacol 160:423–442CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Lerner R, Lutz B, Bindila L (2013) Tricks and tracks in the identification and qualification of endocannabinoids. eLS. Wiley, Chichester. doi: 10.1002/9780470015902.a0023407 Google Scholar
  4. 4.
    Duerr GD, Heinemann JC, Gestrich C et al (2014) Impaired border zone formation and adverse remodeling after reperfused myocardial infarction in cannabinoid CB2 receptor deficient mice. Life Sci 14:324–325Google Scholar
  5. 5.
    Lomazzo E, Bindila L, Remmers F et al (2015) Therapeutic potential of inhibitors of endocannabinoid degradation for the treatment of stress-related hyperalgesia in an animal model of chronic pain. Neuropsychopharmacology 40:488–501CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Jergas B, Schulte K, Bindila L et al (2014) O-2050 facilitates noradrenaline release and increases the CB1 receptor inverse agonistic effect of rimonabant in the guinea pig hippocampus. Naunyn Schmiedebergs Arch Pharmacol 387:621–628CrossRefPubMedGoogle Scholar
  7. 7.
    Wenzel D, Matthey M, Bindila L et al (2013) Endocannabinoid anandamide mediates hypoxic pulmonary vasoconstriction. Proc Natl Acad Sci U S A 110:18710–18715CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  1. 1.Institute for Physiological ChemistryUniversity Medical CenterMainzGermany

Personalised recommendations